홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TGTX
#1195
TG Therapeutics, Inc.
30.0
9
-0.36%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.36%
월간 변동
-2.37%
6달 변화
+5.28%
년간 변동율
+6.33%
이전 종가
30.2
0
Open
30.0
9
Bid
Ask
Low
30.0
9
High
30.0
9
양
136
마켓
주식
헬스케어
TGTX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
140.59 M
142.82 M
146.36 M
154.42 M
157.07 M
—
Valuation ratios
Enterprise value
6.76 B
2.41 B
1.59 B
2.54 B
4.55 B
21.92 B
Price to earnings ratio
—
—
-7.92
189.33
200.67
466.05
Price to sales ratio
—
—
562.55
10.83
14.67
54.61
Price to cash flow ratio
—
—
8.89
80.56
119.11
405.93
Price to book ratio
—
—
0.5
15.77
21.7
39.82
Enterprise value to EBITDA ratio
—
—
—
121.78
108.29
330.68
Profitability ratios
Return on assets %
0.45
0.92
1.02
0.04
0.04
0.43
Return on equity %
0.54
1.47
3.39
0.08
0.11
0.78
Return on invested capital %
1 649.24
2 168.43
1 554.62
145.45
108.67
-220.6
Gross margin %
100
100
100
93.95
88.3
342.12
Operating margin %
180 K
5 154.28
6 924.2
8.83
12.74
60.52
EBITDA margin %
—
—
—
8.92
12.76
77.7
Net margin %
183.8 K
5 204.08
7 121.54
5.42
7.11
267.66
Liquidity ratios
Quick ratio
—
—
—
5.18
5.03
13.91
Current ratio
6.99
5.06
3.16
5.92
6.25
17.96
Inventory turnover
—
—
—
0.35
0.51
0.58
Asset turnover
0
0.01
0.01
0.89
0.73
0.78
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
0.18
0.37
0.3
0.42
1.38
Long term debt to total equity ratio
0
0.02
0.02
0.62
1.1
3.42
Per share metrics
Operating cash flow per share
—
—
1.3
0.21
0.25
0.43
EBIT per share
—
—
—
0.14
0.26
0.64
EBITDA per share
—
—
—
0.14
0.26
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
1.29
1.46
1.94
6.46
Net current asset value per share
—
—
1.24
2.14
3.53
15.3
Tangible book value per share
—
—
22.98
1.08
1.39
8.32
Working capital per share
—
—
0.85
1.78
2.97
11.72
Book value per share
—
—
22.99
1.08
1.39
8.32
뉴스
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG Q4 실적 에상치보다 저조, 수익 예상치를 넘어
TG earnings missed by $0.23, revenue topped estimates
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
TG Therapeutics faces earnings test as Briumvi growth accelerates
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
TG 테라퓨틱스, ACTRIMS 포럼서 브리움비 데이터 발표
TG Therapeutics presents BRIUMVI data at ACTRIMS forum
TG 테라퓨틱스, B.Riley ’매수’ 등급 유지…브리움비 성장세 힘입어
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth
TG 테라퓨틱스, ACTRIMS 포럼서 브리움비 데이터 발표 예정